Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 21, 2016Frontiers in ImmunologyOpen Access

Utilization of Dimethyl Fumarate and Related Molecules for Treatment of Multiple Sclerosis, Cancer, and Other Diseases

View Full Paper
Ask AI
Bookmark
Share

Authors

ZAZaidoon Al‐JaderiAMAzzam A. MaghazachiUniversity of Sharjah

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Al‐Jaderi et al. (2016) studied this question.

synapsesocial.com/papers/6a96ca6ac00de92d9bfbd047https://doi.org/10.3389/fimmu.2016.00278
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS2015 · 196 citations
  2. 2Fumaric Acid and its Esters: An Emerging Treatment for Multiple Sclerosis2009 · 138 citations
  3. 3Molecular mechanisms of Nrf2‐mediated antioxidant response2008 · 791 citations
  4. 4Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic use1999 · 215 citations